Material science firm Crystal to open lab in China

Singapore: Crystal Pharmatech is going to open its laboratories in China in order to provide customized, materials scie...

January 2, 2013 | Wednesday | News
Mindray re-elects its directors

Singapore: Shareholders of Mindray Medical, a leading developer, manufacturer and marketer of medical devices, have re-e...

January 2, 2013 | Wednesday | News
Life Tech Sanger sequencer gets China SFDA nod

Singapore: Life Technologies announced that its Applied Biosystems 3500xL Dx Genetic Analyzer has been approved by Chin...

March 28, 2013 | Thursday | News
EntreMed gets funding from China investors

Singapore: EntreMed, a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, has re...

March 11, 2013 | Monday | News
China Nepstar disposes 40% equity ownership in Yunnan Jianzhijia

Singapore: China Nepstar Chain Drugstore has completed the sales of its 40 percent equity ownership in Yunnan Jianzhijia...

April 24, 2014 | Thursday | News
China vigilant on drug price policy

Singapore: A team of China's National Health and Family Planning Commission (NHFPC) led by Mr Li Xi, head, Permanent Dis...

August 6, 2013 | Tuesday | Regulatory
Parexel opens its 6th office in China

Singapore: Parexel International opened a new office in Shenyang, China. This location will support growing client deman...

May 17, 2013 | Friday | News
ShangPharma celebrates 10 years with Eli Lilly

Singapore: ShangPharma, a China-based pharmaceutical and biotechnology research and development outsourcing company, cel...

June 5, 2012 | Tuesday | News
Top 20 APAC Country Analysis: Korea

Singapore: South Korea is the fourth largest contributor to the lifescience market in the region. • Korean Minis...

June 20, 2015 | Saturday | Analysis
A time to rethink talent management

        Year 2011 was an action-packed-year for HR professionals in Asia Pacific life sciences industry. It te...

May 29, 2012 | Tuesday | Opinion
John Crowley is Charles River's CAO

Singapore: Charles River Laboratories has appointed Mr John Crowley to the role of corporate senior VP, corporate contro...

September 27, 2013 | Friday | Influencers
Zhejiang Medicine, Ambrx to develop antibody drug conjugate for breast cancer

Singapore: Clinical stage biopharmaceutical company, Ambrx and China's Zhejiang Medicine (ZMC) have formed a collaborati...

April 24, 2014 | Thursday | News
Innovative way to meet the global HSA requirement

Human serum albumin (HSA), a blood protein that is widely used in drug and vaccine production, is in high demand around ...

March 26, 2012 | Monday | News
BGI-Shenzhen extends tender offer for Complete Genomics

Singapore: BGI-Shenzhen (BGI) announced that it, through its wholly owned subsidiary Beta Acquisition, has extended its...

April 24, 2013 | Wednesday | News
China Botanic gets warning from NYSE

Singapore: China Botanic Pharmaceutical (formerly Renhuang Pharmaceuticals) received a warning letter from the NYSE MKT...

January 16, 2013 | Wednesday | News
New strategies drive growth in Yunnan Baiyao

Yunnan Baiyao made new strategies for 2011 and the year recorded relocation, expansion of the company's business develop...

June 11, 2012 | Monday | Analysis
Biostar signs another $3 mn military contract within a month

Singapore: China-based Biostar Pharmaceuticals signed a one-year agreement, valued at approximately $3.0 million, to man...

October 18, 2012 | Thursday | News
Chinese to get first-ever oral rotavirus vaccine

Singapore: The not-for-profit organization, International Medica Foundation, that works towards the development of a saf...

July 3, 2013 | Wednesday | News